HealthEquity, Inc. (NASDAQ:HQY) Receives Average Rating of "Moderate Buy" from Brokerages

Shares of HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) have received a consensus rating of "Moderate Buy" from the thirteen research firms that are covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. The average 12 month price objective among brokers that have covered the stock in the last year is $107.23.

Several equities research analysts have recently weighed in on HQY shares. Royal Bank of Canada reissued an "outperform" rating and set a $92.00 price objective on shares of HealthEquity in a research note on Wednesday, September 4th. JMP Securities reaffirmed a "market outperform" rating and issued a $105.00 target price on shares of HealthEquity in a research report on Wednesday, September 4th. Barrington Research reaffirmed an "outperform" rating and issued a $105.00 price objective on shares of HealthEquity in a research note on Friday, September 20th. The Goldman Sachs Group initiated coverage on HealthEquity in a report on Friday. They issued a "neutral" rating and a $108.00 target price for the company. Finally, Bank of America upped their price target on shares of HealthEquity from $100.00 to $120.00 and gave the company a "buy" rating in a report on Wednesday.

HealthEquity Stock Up 3.4 %

Shares of NASDAQ:HQY traded up $3.28 during midday trading on Friday, hitting $98.98. 1,561,907 shares of the company's stock traded hands, compared to its average volume of 620,201. The company has a market cap of $8.64 billion, a PE ratio of 82.48, a P/E/G ratio of 1.48 and a beta of 0.52. HealthEquity has a twelve month low of $62.10 and a twelve month high of $101.17. The firm's fifty day moving average price is $85.02 and its two-hundred day moving average price is $81.08. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 4.10.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its quarterly earnings data on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.16. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. The firm had revenue of $299.93 million for the quarter, compared to analysts' expectations of $284.48 million. On average, equities research analysts anticipate that HealthEquity will post 2.27 EPS for the current fiscal year.

Insider Activity

In related news, Director Robert W. Selander sold 8,250 shares of the firm's stock in a transaction on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total transaction of $684,585.00. Following the sale, the director now directly owns 54,719 shares in the company, valued at $4,540,582.62. This trade represents a 13.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Frank Corvino sold 1,039 shares of the company's stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total value of $99,847.90. Following the transaction, the director now directly owns 3,784 shares of the company's stock, valued at $363,642.40. This represents a 21.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 10,536 shares of company stock worth $884,517. Insiders own 2.20% of the company's stock.

Hedge Funds Weigh In On HealthEquity

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in HQY. International Assets Investment Management LLC acquired a new position in HealthEquity during the 2nd quarter worth approximately $35,000. Paladin Wealth LLC bought a new stake in shares of HealthEquity in the 3rd quarter valued at $39,000. GAMMA Investing LLC raised its holdings in shares of HealthEquity by 114.8% during the second quarter. GAMMA Investing LLC now owns 595 shares of the company's stock valued at $51,000 after purchasing an additional 318 shares during the period. Point72 Asia Singapore Pte. Ltd. acquired a new stake in HealthEquity in the second quarter valued at approximately $73,000. Finally, Quarry LP raised its holdings in HealthEquity by 418.8% during the third quarter. Quarry LP now owns 1,349 shares of the company's stock worth $110,000 after buying an additional 1,089 shares during the last quarter. 99.55% of the stock is owned by institutional investors.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.